• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吸入用N-乙酰半胱氨酸联合特布他林的效果。

Effects of inhaled N-acetylcysteine in combination with terbutaline.

作者信息

Stiksa G, Nemcek K, Melin S

出版信息

Eur J Respir Dis. 1984 May;65(4):278-82.

PMID:6723838
Abstract

The additional effect of N-acetylcysteine in combination with inhaled terbutaline was studied in a controlled randomized double-blind cross-over study of one week periods in 22 patients with stable reversible chronic obstructive pulmonary disease. The patients improved clinically, more during the period with acetylcysteine in combination with terbutaline, than during the period with placebo/terbutaline. The differences were particularly noticeable on the parameters 'difficulties in raising sputum' and 'number of coughs'. Seventeen of 22 patients felt greater improvement during the period with acetylcysteine. Also a small improvement in FEV1 was found by addition of acetylcysteine. No side-effects of acetylcysteine were reported in this combination.

摘要

在一项针对22例稳定期可逆性慢性阻塞性肺疾病患者的对照随机双盲交叉研究中,研究了N-乙酰半胱氨酸联合吸入特布他林的附加效果。患者的临床症状有改善,在使用乙酰半胱氨酸联合特布他林的期间比使用安慰剂/特布他林的期间改善更明显。在“咳痰困难”和“咳嗽次数”参数上差异尤为显著。22例患者中有17例在使用乙酰半胱氨酸期间感觉改善更明显。添加乙酰半胱氨酸后,第一秒用力呼气容积(FEV1)也有小幅改善。该联合用药未报告乙酰半胱氨酸的副作用。

相似文献

1
Effects of inhaled N-acetylcysteine in combination with terbutaline.吸入用N-乙酰半胱氨酸联合特布他林的效果。
Eur J Respir Dis. 1984 May;65(4):278-82.
2
The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
Eur J Respir Dis. 1982 Jan;63(1):13-22.
3
Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?吸入方式是否会影响重度慢性阻塞性肺疾病(COPD)患者的支气管扩张剂反应?
Respir Med. 2001 Jun;95(6):476-83. doi: 10.1053/rmed.2001.1071.
4
Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.口服NAB 365(克仑特罗)和特布他林治疗慢性阻塞性肺疾病:一项双盲、为期两周的研究。
Int J Clin Pharmacol Ther Toxicol. 1980 Jan;18(1):21-5.
5
[Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].[吸入布地奈德对轻至中度慢性阻塞性肺疾病患者的长期影响。奥斯特布罗研究]
Ugeskr Laeger. 2000 Jan 24;162(4):493-7.
6
N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test.N-乙酰半胱氨酸可改善肺功能测试正常的芥子气暴露患者的临床状况。
Basic Clin Pharmacol Toxicol. 2008 Nov;103(5):428-32. doi: 10.1111/j.1742-7843.2008.00318.x. Epub 2008 Sep 17.
7
Nebulized terbutaline and positive expiratory pressure in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中雾化特布他林与呼气末正压通气
Pneumologie. 1991 Mar;45(3):105-9.
8
A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease.对19例慢性阻塞性气道疾病患者使用莫纳根IPPB - M 515吸入异丙托溴铵和特布他林的支气管扩张作用进行的对比研究。
Scand J Respir Dis Suppl. 1979;103:178-82.
9
[Therapy of respiratory tract diseases with N-acetylcysteine. An open therapeutic observation study of 2,512 patients].N-乙酰半胱氨酸治疗呼吸道疾病。对2512例患者的开放性治疗观察研究
Fortschr Med. 1992 Jun 30;110(18):346-50.
10
Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.特布他林与茶碱单独及联合使用对慢性阻塞性肺疾病患者的支气管扩张作用。
Allergol Immunopathol (Madr). 1985 Nov-Dec;13(6):471-4.

引用本文的文献

1
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.布地奈德/福莫特罗、孟鲁司特及N-乙酰半胱氨酸对造血干细胞移植后闭塞性细支气管炎综合征的治疗效果
Respir Res. 2016 May 26;17(1):63. doi: 10.1186/s12931-016-0380-1.
2
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.用于稳定期慢性阻塞性肺疾病的短效β2激动剂
Cochrane Database Syst Rev. 2000;2002(2):CD001495. doi: 10.1002/14651858.CD001495.